GPS Wealth Strategies Group LLC Buys 2,125 Shares of Colgate-Palmolive (NYSE:CL)

GPS Wealth Strategies Group LLC raised its stake in shares of Colgate-Palmolive (NYSE:CL) by 49.4% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 6,430 shares of the company’s stock after purchasing an additional 2,125 shares during the quarter. GPS Wealth Strategies Group LLC’s holdings in Colgate-Palmolive were worth $624,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also bought and sold shares of CL. Federated Hermes Inc. raised its holdings in shares of Colgate-Palmolive by 560.2% during the 4th quarter. Federated Hermes Inc. now owns 288,537 shares of the company’s stock valued at $22,999,000 after buying an additional 244,834 shares in the last quarter. Mitchell Sinkler & Starr PA raised its stake in shares of Colgate-Palmolive by 92.6% during the fourth quarter. Mitchell Sinkler & Starr PA now owns 45,899 shares of the company’s stock worth $3,659,000 after acquiring an additional 22,073 shares in the last quarter. Xponance Inc. lifted its holdings in shares of Colgate-Palmolive by 7.9% in the 4th quarter. Xponance Inc. now owns 182,775 shares of the company’s stock worth $14,569,000 after acquiring an additional 13,342 shares during the last quarter. Stonehage Fleming Financial Services Holdings Ltd boosted its stake in shares of Colgate-Palmolive by 57.1% in the 4th quarter. Stonehage Fleming Financial Services Holdings Ltd now owns 383,819 shares of the company’s stock valued at $30,594,000 after purchasing an additional 139,429 shares in the last quarter. Finally, D L Carlson Investment Group Inc. bought a new position in shares of Colgate-Palmolive during the 4th quarter valued at $3,269,000. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Price Performance

CL traded down $0.56 during midday trading on Thursday, hitting $101.62. 781,871 shares of the company traded hands, compared to its average volume of 4,398,838. The company has a current ratio of 1.06, a quick ratio of 0.28 and a debt-to-equity ratio of 16.90. The company has a market capitalization of $83.37 billion, a price-to-earnings ratio of 32.32, a PEG ratio of 3.54 and a beta of 0.39. Colgate-Palmolive has a 52-week low of $67.62 and a 52-week high of $104.15. The business has a 50 day simple moving average of $97.98 and a two-hundred day simple moving average of $92.00.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, July 26th. The company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.87 by $0.04. The firm had revenue of $5.06 billion for the quarter, compared to the consensus estimate of $5 billion. Colgate-Palmolive had a net margin of 14.21% and a return on equity of 470.19%. The company’s revenue for the quarter was up 4.9% on a year-over-year basis. During the same period last year, the firm posted $0.77 earnings per share. On average, equities analysts forecast that Colgate-Palmolive will post 3.57 earnings per share for the current fiscal year.

Colgate-Palmolive Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, August 15th. Shareholders of record on Friday, July 19th will be paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 1.97%. The ex-dividend date of this dividend is Friday, July 19th. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 63.29%.

Analysts Set New Price Targets

CL has been the topic of several recent research reports. Wells Fargo & Company raised their price target on Colgate-Palmolive from $92.00 to $97.00 and gave the stock an “equal weight” rating in a research report on Wednesday, July 10th. Jefferies Financial Group cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and cut their target price for the stock from $103.00 to $95.00 in a report on Wednesday, July 24th. Royal Bank of Canada upped their price target on shares of Colgate-Palmolive from $88.00 to $95.00 and gave the company a “sector perform” rating in a report on Monday, April 29th. Redburn Atlantic raised shares of Colgate-Palmolive to a “hold” rating in a report on Thursday, August 1st. Finally, Hsbc Global Res downgraded shares of Colgate-Palmolive from a “strong-buy” rating to a “hold” rating in a research note on Friday, July 26th. Eight investment analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. According to MarketBeat.com, Colgate-Palmolive has an average rating of “Moderate Buy” and an average target price of $101.11.

Insiders Place Their Bets

In other Colgate-Palmolive news, insider Panagiotis Tsourapas sold 14,794 shares of Colgate-Palmolive stock in a transaction dated Thursday, August 8th. The shares were sold at an average price of $102.94, for a total transaction of $1,522,894.36. Following the transaction, the insider now directly owns 5,146 shares of the company’s stock, valued at $529,729.24. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other Colgate-Palmolive news, insider Panagiotis Tsourapas sold 14,794 shares of Colgate-Palmolive stock in a transaction dated Thursday, August 8th. The shares were sold at an average price of $102.94, for a total transaction of $1,522,894.36. Following the completion of the sale, the insider now directly owns 5,146 shares in the company, valued at $529,729.24. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Sally Massey sold 15,850 shares of Colgate-Palmolive stock in a transaction dated Tuesday, August 6th. The shares were sold at an average price of $103.28, for a total transaction of $1,636,988.00. Following the sale, the insider now owns 13,942 shares of the company’s stock, valued at $1,439,929.76. The disclosure for this sale can be found here. Insiders have sold 41,177 shares of company stock valued at $4,245,835 over the last ninety days. Company insiders own 0.34% of the company’s stock.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.